953 / 1674
Conclusion
In favor of VMAT:
Better dose conformity, less dose to non-target breast tissue, MHD reduced in
particular in patients where MHD >0.5 Gy with 3D CRT, less dose to
ipsilateral lung
Not in favor of VMAT:
Slight (but acceptable) increase in dose to contralateral breast and lung
Essers et al, Acta Oncol 2014
Is there a role for VMAT and DIBH in APBI?